首页> 外国专利> Plasmid, composition, process of immunizing an individual against a pathogen, recombinant vaccine, live attenuated pathogen, substantially pure bl-1 protein, recombinant expression vector, and isolated antibody

Plasmid, composition, process of immunizing an individual against a pathogen, recombinant vaccine, live attenuated pathogen, substantially pure bl-1 protein, recombinant expression vector, and isolated antibody

机译:质粒,组合物,针对病原体免疫个体的方法,重组疫苗,减毒活病原体,基本纯的bl-1蛋白,重组表达载体和分离的抗体

摘要

'' PLASMID, COMPOSITION, IMMUNIZATION PROCESS OF AN INDIVIDUAL AGAINST A PATHOGEN, RECOMBINANT VACCINE, ATTENTIONED LIVE PATHOGEN, SUBSTANTIALLY PURE PROTEIN, EXCELLENT VECTOR ISOLATED, 'EOL'. Enhanced vaccines are presented, which include a nucleotide sequence encoding IL-12, GM-CSF, IL-1, TNF- 244, TNF- 225, IL-2, IL-4, IL-5, IL -10, IL-15, IL-18 AND / OR BL-1 operably linked to regulatory elements. Enhanced vaccines include DNA vaccines, recombinant vaccines for foreign antigen release and live attenuated vaccines. Immunization processes of individuals are presented. Pharmaceutical compositions are presented comprising nucleic acid molecules that encode one or more immunomodulatory proteins selected from the group consisting of IL-12, GM-CSF, IL-1, TNF- 244, TNF- 225, IL-2, IL -4, IL-5, IL10, IL-15, IL-18 AND BL-1. An immunomodulatory protein, BL-1, and nucleic acid molecules that encode BL-1, are presented. Processes for producing and using BL-1 are presented.
机译:''病原体,重组疫苗,注意活体病原体,基本纯净的蛋白质,优良的矢量隔离,'EOL'的个体的质粒,组成,免疫过程。提出了增强的疫苗,其包括编码IL-12,GM-CSF,IL-1,TNF- <244>,TNF- <225>,IL-2,IL-4,IL-5,IL -10的核苷酸序列。 ,IL-15,IL-18和/或BL-1可操作地连接至调节元件。增强疫苗包括DNA疫苗,用于外源抗原释放的重组疫苗和减毒活疫苗。介绍了个人的免疫过程。提出了药物组合物,其包含编码一种或多种选自IL-12,GM-CSF,IL-1,TNF- <244>,TNF- <225>,IL-2,IL的一种或多种免疫调节蛋白的核酸分子。 -4,IL-5,IL10,IL-15,IL-18和BL-1。提出了一种免疫调节蛋白BL-1和编码BL-1的核酸分子。介绍了生产和使用BL-1的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号